![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_995dfb74d285a9d0ae9b80e3f0f3c2e9.svg) | 12,14-Dimethyl-9-(5-methylfuran-2-yl)-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 250.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_e9340ac8ebb5e53d227ef5e5edd7bc9d.svg) | CFTR(inh)-172 | IC50 | 300.0 [1], 380.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_48f023638ecd733deac09c86b939ac53.svg) | BPO-27 (racemate) | IC50 | 8.0 [1], 40.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_0aba9404894e8db8bea7e7e4116e46b9.svg) | 9-(5-Bromofuran-2-yl)-12,14-dimethyl-17-phenyl-8-oxa-1,12,14-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 90.0 [1], 200.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_3562fc4527f55da53a5862533bccaf6d.svg) | 9-(5-Bromofuran-2-yl)-12,14-dimethyl-4-nitro-17-phenyl-8-oxa-1,12,14-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-2(7),3,5,10,16-pentaene-13,15-dione | IC50 | 25.0 [1], 120.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_acada44807afe03ada536ebebd5d80a0.svg) | 12,14-Dimethyl-9-(5-methylfuran-2-yl)-4-nitro-17-phenyl-8-oxa-1,12,14-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-2(7),3,5,10,16-pentaene-13,15-dione | IC50 | 25.0 [1], 100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_10f6d17f6085f9d1ff2483478c5a9ba1.svg) | Ethyl 9-(5-bromofuran-2-yl)-12,14-dimethyl-13,15-dioxo-17-phenyl-8-oxa-1,12,14-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-2(7),3,5,10,16-pentaene-4-carboxylate | IC50 | 25.0 [1], 50.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_ec5b1f04dbdcf1887ef47c5eb7326ace.svg) | 9-(5-Bromofuran-2-yl)-12,14-dimethyl-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 50.0 [1], 90.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_6485e328de946f848a02a213ed5d7d84.svg) | 9-(5-Iodofuran-2-yl)-12,14-dimethyl-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 100.0 [1], 170.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_7678391665350c8597f29638df219c3b.svg) | Glyburide | IC50 | 15000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_a2cf57bd6f8c46fcf64697efa5bb4d5b.svg) | Apigenin | Ki | 81000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_59b978831ca42e6ea897bf57e8c301e5.svg) | N-[(E)-(3,5-Dibromo-2,4-dihydroxyphenyl)methylideneamino]-2-(naphthalen-2-ylamino)acetamide | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_a5798da42f94f3d9006d0f8dd7789e76.svg) | N-(2-(5-Chloro-2-methoxyphenylamino)-4'-methyl-4,5'-bithiazol-2'-yl)benzamide | IC50 | 6000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_99c1db06822898bdd6adeff9f8474231.svg) | 2-(1-Hydroxypentyl)-6-methyl-3-(2-phenylethyl)-1H-Indole-5-carboxylic acid | IC50 | 160000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_b5259ac8df525642b52f8bdcc1bf515c.svg) | 12,14-Dimethyl-9-(3-nitrophenyl)-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 1200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_531a1eeee217371db6f247ea3a6eb9d4.svg) | 4,5,12,14-Tetramethyl-9-(5-methylfuran-2-yl)-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2(7),3,5,10,16-pentaene-13,15-dione | IC50 | 800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_2cb88bb6980b581476026e96f2fc0988.svg) | N-[12-(5-Chloro-2-methoxyanilino)-3,11-dithia-5,13-diazatricyclo[8.3.0.02,6]trideca-1(10),2(6),4,12-tetraen-4-yl]-2,2-dimethylpropanamide | IC50 | 2300.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_251cad85420259235f2de1774ee7c43d.svg) | 2-((2-Carboxyethyl)carbamoyl)-6-methyl-3-phenethyl-1H-indole-5-carboxylic acid | IC50 | 490000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_f71f2ad758a1380e4f9e2aedc468e344.svg) | 4-((4-Oxo-2-thioxo-3-(4-(trifluoromethyl)phenyl)thiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 15000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_33cb103bbf44a83256153f5864424d63.svg) | 3-(Hydroxymethyl)-5-methyl-2-pentyl-1-phenethyl-1H-indole-6-carboxylic acid | IC50 | 380000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_dee9c111984a4c0c68d28cee98d5883b.svg) | N-[12-(5-Chloro-2-methoxyanilino)-3,11-dithia-5,13-diazatricyclo[8.3.0.02,6]trideca-1(10),2(6),4,12-tetraen-4-yl]cyclopropanecarboxamide | IC50 | 8900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_c17f1e2e41344083ff420455399b0961.svg) | N-[12-(5-Chloro-2-methoxyanilino)-3,11-dithia-5,13-diazatricyclo[8.3.0.02,6]trideca-1(10),2(6),4,12-tetraen-4-yl]-2-methylpropanamide | IC50 | 5800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_3a4b86980576a952f5d5c329ad2870dd.svg) | N-[12-(5-Chloro-2-methoxyanilino)-3,11-dithia-5,13-diazatricyclo[8.3.0.02,6]trideca-1(10),2(6),4,12-tetraen-4-yl]-2-methylbutanamide | IC50 | 6600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_9c00eddb86bab82d35a05fc21dfb0e72.svg) | Methyl 4-[[12-(5-chloro-2-methoxyanilino)-3,11-dithia-5,13-diazatricyclo[8.3.0.02,6]trideca-1(10),2(6),4,12-tetraen-4-yl]amino]-4-oxobutanoate | IC50 | 8800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_543c2798d35130b201be9f67fcef8a83.svg) | N-[12-(5-Chloro-2-methoxyanilino)-3,11-dithia-5,13-diazatricyclo[8.3.0.02,6]trideca-1(10),2(6),4,12-tetraen-4-yl]-1,2-oxazole-5-carboxamide | IC50 | 4800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_8f894d63f086c5c9e6c2260d788e1e25.svg) | N-[12-[5-Chloro-2-(dimethylamino)anilino]-3,11-dithia-5,13-diazatricyclo[8.3.0.02,6]trideca-1(10),2(6),4,12-tetraen-4-yl]-2,2-dimethylpropanamide | IC50 | 6900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_ae6179a52970d633d15c61a7bc4cca3c.svg) | 2,2-Dimethyl-N-[12-[(3-methylpyridin-2-yl)amino]-3,11-dithia-5,13-diazatricyclo[8.3.0.02,6]trideca-1(10),2(6),4,12-tetraen-4-yl]propanamide | IC50 | 7200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_4e05f830ea0cba3f28583aeaabcebfb2.svg) | N-[12-[3-(Dimethylamino)anilino]-3,11-dithia-5,13-diazatricyclo[8.3.0.02,6]trideca-1(10),2(6),4,12-tetraen-4-yl]-2,2-dimethylpropanamide | IC50 | 2200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_b7c558f0823bf8d7d429ea8b9d221000.svg) | N-[12-(2-Methoxy-5-nitroanilino)-3,11-dithia-5,13-diazatricyclo[8.3.0.02,6]trideca-1(10),2(6),4,12-tetraen-4-yl]-2,2-dimethylpropanamide | IC50 | 3600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_e812ce523f9dcd60a09e9174070d30b6.svg) | 2-(3-((4-Oxo-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-5-ylidene)methyl)phenoxy)acetic acid | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_a2aad1ee7541d684ea666624f19ef77d.svg) | 3-((4-Oxo-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 1500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_c8fb903b0054a3fe96aec810f7a1c1ef.svg) | (Z)-5-(4-(1H-Tetrazol-5-yl)benzylidene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-one | IC50 | 760.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_0c0b886462cd31efda9a7bf8b0b16c6e.svg) | 5-(4-(2H-Tetrazol-5-yl)benzylidene)-3-(3-(trifluoromethyl)phenyl)thiazolidine-2,4-dione | IC50 | 17000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_3856a89dbfd1cf7ba5ac8df69ba7f293.svg) | (2S,3S,4R)-3,4-Dihydroxy-2,4-dimethyl-3H-pyrimido[2,1-a]isoquinoline-2-carboxylic acid | IC50 | 15.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_9dcc097d9ad6fd7e84b96ab22dbcc3f1.svg) | (2R,4S,5R,6S)-2-Nonyl-6-phenyl-7-oxa-1-azabicyclo[3.2.1]octan-4-ol | IC50 | 58620.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_3ba349619936e127341e32d7aea1a628.svg) | (Z)-4-((3-(2,3-Dimethylphenyl)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 7000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_7551d01dc8eab97c6a15f2085d6e45fc.svg) | 5-(4-Pyridinylmethylene)-2-thioxo-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-4-one | IC50 | 28000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_fedcc103f866e6ede0ee4b77fb0f0bf1.svg) | 4-[[4-Chloro-2,5-dioxo-1-[3-(trifluoromethyl)phenyl]pyrrol-3-yl]amino]benzoic acid | IC50 | 36000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_45c14a2dbef5031a7237ec004b817edb.svg) | 2-(4-((4-Oxo-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-5-ylidene)methyl)phenoxy)acetic acid | IC50 | 2600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_af35d46cc3840aa88289049f9a4765d0.svg) | (5Z)-5-(4-Hydroxybenzylidene)-2-thioxo-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-4-one | IC50 | 24000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_396cb5170698a502716b3fc71857612b.svg) | 9-(3-Chlorophenyl)-17-(2-fluorophenyl)-12,14-dimethyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 2500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_1cf74b8588b9a69712ab46cae5433aff.svg) | 17-(2-Fluorophenyl)-4,5,12,14-tetramethyl-9-(5-methylfuran-2-yl)-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2(7),3,5,10,16-pentaene-13,15-dione | IC50 | 1500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_ce90733519f00e25181cc17fae25a361.svg) | 5-(3,5-Dibromo-4-hydroxybenzylidene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-one | IC50 | 7000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_83fd5237251757bd010d192538f66caf.svg) | 2-((4-Oxo-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 15000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_0da26682b898719cc7c78159f138d0c3.svg) | 9-(4-Hydroxyphenyl)-12,14-dimethyl-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 4500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_db48081de01f06ba7572dc49ad27cc0b.svg) | 9-(2-Fluorophenyl)-12,14-dimethyl-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_574843a4c379dd264b117a78a70912be.svg) | 9-(3-Methoxyphenyl)-12,14-dimethyl-17-(3-methylphenyl)-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 1700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_c9afe14206022f76928f88bcfa7fa1ca.svg) | 9-(3-Fluorophenyl)-12,14-dimethyl-17-(3-methylphenyl)-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 8000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_671ccbddcd9110e55e1b337a09acda1b.svg) | 9-(2-Fluorophenyl)-12,14-dimethyl-17-(3-methylphenyl)-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 2500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_df4ff1706a0293b85ed84635a8863f8d.svg) | 12,14-Dimethyl-17-(2-methylphenyl)-9-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_cfbb63db6c888487464f4f93f4f261b6.svg) | 12,14-Dimethyl-17-(2-methylphenyl)-9-(3-methylphenyl)-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_1d4dbbf770cb7248f05fda25b1d0fd61.svg) | 9-(3-Methoxyphenyl)-12,14-dimethyl-17-(2-methylphenyl)-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_881deb5966f0393c4abdd3aba6fab243.svg) | 9-(4-Hydroxyphenyl)-4,5,12,14-tetramethyl-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2(7),3,5,10,16-pentaene-13,15-dione | IC50 | 1500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_bfac5c326a37b8ac56bdac9e4138cb44.svg) | 4-((4-Oxo-2-thioxo-3-(2-(trifluoromethyl)phenyl)thiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 12000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_2886ee41742f847f7ae25222f4b3fc0c.svg) | 2-Hydroxy-5-((4-oxo-2-thioxo-3-(2-(trifluoromethyl)phenyl)thiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 14000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_97d2d69b1beda08f3a1a7bf22c1efd9f.svg) | 2-(4-Carboxybutyl)-3-(hydroxymethyl)-5-methyl-1-(2-phenylethyl)indole-6-carboxylic acid | IC50 | 170000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_37e716bb7bec019532b15bb5d72355a0.svg) | 12-N-(5-Chloro-2-methoxyphenyl)-3,11-dithia-5,13-diazatricyclo[8.3.0.02,6]trideca-1(10),2(6),4,12-tetraene-4,12-diamine | IC50 | 11000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_7319f8fd9bd07842e40b126fd542b6f6.svg) | N-[13-(5-Chloro-2-methoxyanilino)-3,12-dithia-5,14-diazatricyclo[9.3.0.02,6]tetradeca-1(11),2(6),4,13-tetraen-4-yl]-2,2-dimethylpropanamide | IC50 | 4100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_27fb03f471624b767d50ab38aa0d5917.svg) | 9-(3-Methoxyphenyl)-12,14-dimethyl-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 1700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_c2c03f88e192e165c45f7f9a8a97331d.svg) | 4-[2,5-Dioxo-1-[3-(trifluoromethyl)phenyl]pyrrolidin-3-yl]sulfanylbenzoic acid | IC50 | 7000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_a380bc632ed4f32729df4820579764c5.svg) | 2-Hydroxy-5-[(Z)-[4-oxo-2-sulfanylidene-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-5-ylidene]methyl]benzoic acid | IC50 | 1400.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_528b4516b9d68a1bb08dcb447ddcb9d6.svg) | (5Z)-2-Sulfanylidene-3-[3-(trifluoromethyl)phenyl]-5-[(3,4,5-trihydroxyphenyl)methylidene]-1,3-thiazolidin-4-one | IC50 | 11000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_28664b88dc6b55bda434bf430f9b487f.svg) | 4-((3-(4-Fluoro-3-(trifluoromethyl)phenyl)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 1500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_f261ac4d0ed3213f9d1300263853fee1.svg) | 4-((3-(4-Chloro-3-(trifluoromethyl)phenyl)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 15000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_e604bca5fd9291b87406b20655dd4f42.svg) | 4-((3-(3,5-Bis(trifluoromethyl)phenyl)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 14000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_1550f7cda80e6f65264368b5bd160bae.svg) | 3-((3-(4-Fluoro-3-(trifluoromethyl)phenyl)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_4cf3a113623fc2b82ae155882c8965d0.svg) | 4-[[4-Oxo-2-sulfanylidene-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidine-5-carbothioyl]amino]benzoic acid | IC50 | 9000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_12e5ba733db50c72dc3f1bb6ea772f92.svg) | 5-(3,5-Dibromo-2,4-dihydroxybenzylidene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-one | IC50 | 8000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_e65ef0d809f8237ee57de8b143e433b7.svg) | (5Z)-5-[(1-Oxidopyridin-1-ium-4-yl)methylidene]-2-sulfanylidene-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-4-one | IC50 | 8700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_432130cdb7b1577b1715d1bccbb03fca.svg) | 4-[[4-Oxo-2-thioxo-3-[2-methyl-3-(trifluoromethyl)phenyl]-5-thiazolidinylidene]methyl] benzoic acid | IC50 | 8200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_eb0ca3986736165c8de59fa398adb13a.svg) | 2-(4-Carboxy-1-hydroxybutyl)-6-methyl-3-(2-phenylethyl)-1H-indole-5-carboxylic acid | IC50 | 330000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_7b9b777bdfc5d7667761b53a7737ad01.svg) | 2-Hydroxy-4-[[4-oxo-2-sulfanylidene-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidine-5-carbothioyl]amino]benzoic acid | IC50 | 25000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_dc385248c4b0b4331293187df59c0a5a.svg) | 4-[[4-Oxo-2-sulfanylidene-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-5-yl]methyl]benzoic acid | IC50 | 27000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_31e09fba10eb7da7ea16ec5fc08d2918.svg) | 4-(4-(3-(Trifluoromethyl)phenyl)thiazol-2-ylamino)benzoic acid | IC50 | 28000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_2a9667a6fc75f91063d1f4ba38feddc6.svg) | 2-Hydroxy-5-(4-(3-(trifluoromethyl)phenyl)thiazol-2-ylamino)benzoic acid | IC50 | 32000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_f5a8fdd308b59667c619e77c3cb3f328.svg) | 4-((4-Oxo-2-thioxo-3-m-tolylthiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_e10545829a4160ced7874c37f5e82991.svg) | 3-((4-Oxo-2-thioxo-3-(4-(trifluoromethyl)phenyl)thiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 13000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_55f6fd99702771b9c1b2056109df0f0e.svg) | 2-((4-Oxo-2-thioxo-3-(2-(trifluoromethyl)phenyl)thiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 18000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_2f5f561868e5f0bf0d01ce3886dadcda.svg) | 3-((4-Oxo-2-thioxo-3-(2-(trifluoromethyl)phenyl)thiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 19000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_9c4a44fc6bc3d99925e6f68ff18fc16a.svg) | 2-((4-Oxo-2-thioxo-3-(4-(trifluoromethyl)phenyl)thiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_c4d97b5daa98183dceb1486dda7bc318.svg) | 4-[(Z)-[3-[2-Chloro-5-(trifluoromethyl)phenyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]benzoic acid | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_fe29d240597bc26edafd6b711a4fc0a8.svg) | 2-Hydroxy-5-((4-oxo-2-thioxo-3-(4-(trifluoromethyl)phenyl)thiazolidin-5-ylidene)methyl)benzoic acid | IC50 | 25000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_53c40560bf48250a175a8913a6b8f249.svg) | (5Z)-2-Sulfanylidene-3-[3-(trifluoromethyl)phenyl]-5-[(2,3,4-trihydroxyphenyl)methylidene]-1,3-thiazolidin-4-one | IC50 | 28000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_607f072dfc6bf776daa5676c69c5575f.svg) | 12,14-Dimethyl-9-(5-methylfuran-2-yl)-17-(3-methylphenyl)-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_1642e8c46660d0c4a1ea9b16d599b4dc.svg) | 12,14-Dimethyl-9,17-diphenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 2500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_fa560bedd8955d99c2ae28d9bc098ec7.svg) | 9-(4-Hydroxy-2-methoxyphenyl)-12,14-dimethyl-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_13de39696cae390b64db083f7b87482a.svg) | 9-(2,3-Difluorophenyl)-12,14-dimethyl-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 1200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_5ee1c74fc22d539916ee8bce1115dcde.svg) | 9-(4-Hydroxyphenyl)-12,14-dimethyl-17-(3-methylphenyl)-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 1700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_344f1be164b804ad73bca19cadeb8715.svg) | 12,14-Dimethyl-17-(2-methylphenyl)-9-(3-nitrophenyl)-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_4ed00adb6f526bedd1737c2adf6d36ef.svg) | 12,14-Dimethyl-9-(5-methylfuran-2-yl)-17-(2-methylphenyl)-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_d713e11a624c3a19bdcaa89b7fcb2ad9.svg) | 17-(2-Fluorophenyl)-9-(3-methoxyphenyl)-12,14-dimethyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_eadd0107aa6603a166bb8ee616bf9c95.svg) | 9-(2-Fluoro-3-nitrophenyl)-12,14-dimethyl-17-(3-methylphenyl)-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 2000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_44cfc66015e26cf4893f3df1f6a047b1.svg) | 9-(5-Iodofuran-2-yl)-12,14-dimethyl-17-phenyl-8-oxa-1,12,14-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_084f6d96973f097f6010ea0a80247cac.svg) | 12,14-Dimethyl-9-(5-methylfuran-2-yl)-17-phenyl-8-oxa-1,12,14-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 150.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_9f4efab1dfbf70f5f2dded00438fb175.svg) | 9-(5-Chlorofuran-2-yl)-12,14-dimethyl-17-(3-methylphenyl)-8-oxa-1,12,14-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 370.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_01681c63eb362873cdb2a79d3008f59f.svg) | 12,14-Dimethyl-9-(5-methylfuran-2-yl)-17-(3-methylphenyl)-8-oxa-1,12,14-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_24c97eb98beb154af1ed8e855f2f0630.svg) | 9-(5-Bromofuran-2-yl)-12,14-dimethyl-4-nitro-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2(7),3,5,10,16-pentaene-13,15-dione | IC50 | 170.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_53ece022e4d78b1e85e900b9fe40f37d.svg) | 4-Chloro-12,14-dimethyl-9-(5-methylfuran-2-yl)-5-nitro-17-phenyl-8-oxa-1,12,14-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 170.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_6cc7ca1740c4a284a939f01a6ef0f628.svg) | Ethyl 12,14-dimethyl-9-(5-methylfuran-2-yl)-13,15-dioxo-17-phenyl-8-oxa-1,12,14-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-2(7),3,5,10,16-pentaene-4-carboxylate | IC50 | 80.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cystic-fibrosis-transmembrane-conductance-regulator_e0b5a8b33b62f061ee2f902e422f50ae.svg) | 12,14-Dimethyl-9-(5-methylfuran-2-yl)-8-nitroso-17-phenyl-1,8,12,14-tetrazatetracyclo[8.7.0.02,7.011,16]heptadeca-2,4,6,10,16-pentaene-13,15-dione | IC50 | 2000.0 [1] |